These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Computed Tomography Imaging for Monitoring of Marburg Virus Disease: a Nonhuman Primate Proof-Of-Concept Study. Sword J; Lee JH; Castro MA; Solomon J; Aiosa N; Reza SMS; Chu WT; Johnson JC; Bartos C; Cooper K; Jahrling PB; Johnson RF; Calcagno C; Crozier I; Kuhn JH; Hensley LE; Feuerstein IM; Mani V Microbiol Spectr; 2023 Jun; 11(3):e0349422. PubMed ID: 37036346 [TBL] [Abstract][Full Text] [Related]
10. Novel antiviral approaches for Marburg: a promising therapeutics in the pipeline. Srivastava S; Kumar S; Ashique S; Sridhar SB; Shareef J; Thomas S Front Microbiol; 2024; 15():1387628. PubMed ID: 38725678 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomics of Marburg virus-infected primary proximal tubular cells reveals negative correlation of immune response and energy metabolism. Koch B; Filzmayer M; Patyna S; Wetzstein N; Lampe S; Schmid T; Geiger H; Baer PC; Dolnik O Virus Res; 2024 Apr; 342():199337. PubMed ID: 38346476 [TBL] [Abstract][Full Text] [Related]
12. New Insights Into Marburg Virus Disease Pathogenesis in the Rhesus Macaque Model. Cooper TK; Sword J; Johnson JC; Bonilla A; Hart R; Liu DX; Bernbaum JG; Cooper K; Jahrling PB; Hensley LE J Infect Dis; 2018 Nov; 218(suppl_5):S423-S433. PubMed ID: 30053050 [TBL] [Abstract][Full Text] [Related]
13. Infection prevention and control: Qualitative study of the preparedness and response of Christian health Association of Ghana to Marburg virus disease in Ghana. Agboh HNK; Adjei GA; Okai GA; Awotwe C; Ossom BM; Yarney L Heliyon; 2024 Jun; 10(11):e31953. PubMed ID: 38882285 [TBL] [Abstract][Full Text] [Related]
14. Tanzania's first Marburg Viral Disease outbreak response: Describing the roles of FELTP graduates and residents. Hussein AK; Kishimba RS; Simba AA; Urio LJ; Lema NA; Mmbaga VM; Mutayoba BK; Malugu NE; Leonard D; Hokororo J; Kelly ME; Paschal A; Ngenzi D; Hellar JA; Kauki GC; Saguti GE; Yoti Z; Mukurasi KI; Mponela M; Mgomella GS; Gatei W; Kaniki I; Swaminathan M; Kwesi EM; Nagu TJ PLOS Glob Public Health; 2024; 4(5):e0003189. PubMed ID: 38809954 [TBL] [Abstract][Full Text] [Related]
15. The Looming Threat of Dengue Fever: The Africa Context. Mercy K; Youm E; Aliddeki D; Faria NR; Kebede Y; Ndembi N Open Forum Infect Dis; 2024 Jul; 11(7):ofae362. PubMed ID: 38994441 [TBL] [Abstract][Full Text] [Related]
16. The urgency of Marburg therapeutics: preventing local outbreaks from the potential global spread. Suvvari TK; Mahal A; Kandi V; Alotaibi HF; Mishra S; Mohapatra RK Front Microbiol; 2024; 15():1378314. PubMed ID: 39011143 [No Abstract] [Full Text] [Related]
17. Letter to the Editor. Lateral spread responses in predicting MVD outcomes. Cheng WY; Shen CC; Liao CH J Neurosurg; 2024 Apr; ():1-2. PubMed ID: 38669703 [No Abstract] [Full Text] [Related]
18. Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine. Harris PE; Burkholz S; Herst CV; Rubsamen RM Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543955 [TBL] [Abstract][Full Text] [Related]
19. The Current Pathogenicity and Potential Risk Evaluation of Marburg Virus to Cause Mysterious "Disease X"-An Update on Recent Evidences. Mitu RA; Islam MR Environ Health Insights; 2024; 18():11786302241235809. PubMed ID: 38440221 [TBL] [Abstract][Full Text] [Related]